Author Interview: Cheryl Krasnick Warsh on Frances Oldham Kelsey, the FDA, and the Battle Against Thalidomide

Cheryl Krasnick Warsh

Library of Congress

Wednesday, October 23, 2024 12:00 pm EDT

Online via Zoom

Canadian History / Studies, Health and Health Care, History of Science, Medicine, and Technology, Library and Information Science, Women's & Gender History / Studies
In the 1950s, a German company called Chemie Grünenthal claimed discovery of a new wonder drug: a sedative called thalidomide. When the world discovered the drug’s effects – babies who arrived stillborn, with improperly developed organs, or with missing limbs – Americans elevated FDA pharmacologist Frances Oldham Kelsey as a scientific hero, one whose meticulous research had kept the drug from the U.S. market.
 
Warsh’s recent biography, Frances Oldham Kelsey, the FDA, and the Battle against Thalidomide explores Kelsey’s popular elevation as a “good mother of science” and her lifetime commitment to preventing another thalidomide tragedy. Join Library of Congress staff on Wednesday, October 23, 2024, 12:00 PM EDT for a conversation with Dr. Cheryl Krasnick Warsh to reflect on gender and medicine, the history of pharmaceutical regulation, and Kelsey’s battle against thalidomide six decades on.
 
Online via Zoom, Register here.
 
Please request ADA accommodations at least five business days in advance by contacting (202) 707-6362 or ada@loc.gov.
 
Contact Information
Josh Levy, Library of Congress Manuscript Division
 
Contact Email
jlevy@loc.gov
URL
https://loc.zoomgov.com/webinar/register/4617278825374/WN_5SR5T1MiQo6roepCYi2qL…